Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Madrigal Pharmaceuticals, Inc. (MDGL : NSDQ)
 
 • Company Description   
Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-? agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia and high triglycerides; and MGL-3745, a thyroid hormone receptor-? agonist which are in pre-clinical trial stage. Madrigal Pharmaceuticals Inc., formerly known as Synta Pharmaceuticals Corp., is based in Fort Washington, Pennsylvania.

Number of Employees: 915

 
 • Price / Volume Information   
Yesterday's Closing Price: $517.26 Daily Weekly Monthly
20 Day Moving Average: 285,321 shares
Shares Outstanding: 23.06 (millions)
Market Capitalization: $11,925.95 (millions)
Beta: -1.04
52 Week High: $615.00
52 Week Low: $265.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.29% -5.16%
12 Week 16.02% 7.25%
Year To Date -11.18% -18.92%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
200 BARR HARBOR DRIVE SUITE 200
-
WEST CONSHOHOCKEN,PA 19428
USA		 ph: 267-824-2827
fax: 781-274-8228		 ir@madrigalpharma.com http://www.madrigalpharma.com
 
 • General Corporate Information   
Officers
William J. Sibold - President and Chief Executive Officer; Director
Julian C. Baker - Chair of the Board
Mardi C. Dier - Executive Vice President and Chief Financial Offic
Rita Thakkar - Senior Vice President and Chief Accounting Officer
Rebecca Taub - Director

Peer Information
Madrigal Pharmaceuticals, Inc. (GSAC)
Madrigal Pharmaceuticals, Inc. (CASIF)
Madrigal Pharmaceuticals, Inc. (ALCD.)
Madrigal Pharmaceuticals, Inc. (OMNN)
Madrigal Pharmaceuticals, Inc. (CGPI.)
Madrigal Pharmaceuticals, Inc. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 558868105
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/26
Next Expected EPS Date: 08/04/26
Share - Related Items
Shares Outstanding: 23.06
Most Recent Split Date: 7.00 (0.03:1)
Beta: -1.04
Market Capitalization: $11,925.95 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-1.75 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-6.49 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 21.94
Price/Cash Flow: -
Price / Sales: 10.53
EPS Growth
vs. Year Ago Period: 2.11%
vs. Previous Quarter: -26.46%
Sales Growth
vs. Year Ago Period: 126.84%
vs. Previous Quarter: -3.04%
ROE
03/31/26 - -50.15
12/31/25 - -43.76
09/30/25 - -41.50
ROA
03/31/26 - -25.44
12/31/25 - -24.88
09/30/25 - -26.18
Current Ratio
03/31/26 - 3.50
12/31/25 - 4.01
09/30/25 - 3.44
Quick Ratio
03/31/26 - 3.16
12/31/25 - 3.77
09/30/25 - 3.26
Operating Margin
03/31/26 - -27.32
12/31/25 - -30.08
09/30/25 - -39.04
Net Margin
03/31/26 - -27.32
12/31/25 - -30.08
09/30/25 - -39.04
Pre-Tax Margin
03/31/26 - -27.32
12/31/25 - -30.08
09/30/25 - -39.04
Book Value
03/31/26 - 23.57
12/31/25 - 26.54
09/30/25 - 27.55
Inventory Turnover
03/31/26 - 0.98
12/31/25 - 0.85
09/30/25 - 0.63
Debt-to-Equity
03/31/26 - 0.63
12/31/25 - 0.56
09/30/25 - 0.54
Debt-to-Capital
03/31/26 - 38.51
12/31/25 - 36.06
09/30/25 - 35.19
 

Powered by Zacks Investment Research ©